维普中文期刊产品整合服务
123篇 您的检索式:作者名="Gisselbrecht C"
    题名 作者 年代 出处 被引量
1Rituximab plus CHOP(R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma(DLBCL)显示文摘Mounier N Briere J Gisselbrecht C 2003Blood2003,101,11:1
2Rituximab Purging and/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma:a Prospective Randomized Trial From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation显示文摘Pettengell R Schmitz N Gisselbrecht C 0,,3:1
3Rituximab plus CHOP (R- CHOP) overcomes bcl- 2- associated resistance to chemotherapy in elderly patients with diffuse large B-cell lym- phoma (DLBCL) 显示文摘Mounier N Briere J Gisselbrecht C 2003Blood2003,101,11:1
4Survival benefit of high - dose therapy in poor - risk aggressive non- Hodgkin' s lymphoma: final analysis of the prospective LNH87 - 2 protocol - a groupe d ' Etude des lymphomes de l' Aduhe study显示文摘Haioun C Lepage E Gisselbrecht C 2000J Clin Oncol2000,18,:1
5LNH-84regimen a multicenter study of intensive chemotherapy in 737patients with aggressive malignant lymphoma 显示文摘Coiffier B Gisselbrecht C Herbercht R 1989J Clin Oncol1989,7,:1
6High - dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era:An analysis based on data from the European blood and marrow transplantation registry 显示文摘Mounier N Canals C Gisselbrecht C 2012Biol Blood Marrow Transplantat2012,18,5:1
7Control of thronfβopoie- tin-induced mcgakaryocytie diftrentiation by the mitogen-aetivated prntein kinase pathway显示文摘Rouyez M C Bouehron C Gisselbrecht S 1997Mol Cell Binl1997,17,9:1
8In vivo purging and relapse prevention following ASCT 显示文摘Gisselbrecht C 2002Bone Marrow Transplant2002,29,1:1
9Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas显示文摘Ballester B Ramuz O Gisselbrecht C 2006Oncogene2006,25,10:1
10Rituximab mainte- nance therapy after autologous stem-cell transplantation in patients with relapsed CD20(+) diffuse large B-ceil lymphoma: 显示文摘Gisselbrecht C Schmitz N Mounier N 2012J Clin Oncol2012,30,36:1
11Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas(GELA)显示文摘GISSELBRECHT C GAULARD P LEPAGE E 1998Blood1998,92,1:1
12Prognostic significance of T-cell phenotype in aggressive non-Hodgin's lymphomas显示文摘Gisselbrecht C Gaulard P Lepage E 1998Blood1998,92,1:1
13Control of thrombopoi- etin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway 显示文摘Rouyez MC Boucheron C Gisselbrecht S 1997Mol Cell Biol1997,17,9:1
14Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)显示文摘MMOUNIER N BRIERE J GISSELBRECHT C 2003Blood2003,101,11:1
15For the CORAL study group 显示文摘Hagberg H Gisselbrecht C 2006Ann Oncol2006,17,4:1
16Improving second-llne therapy in aggressive non- Hedgkin's lymphoma 显示文摘Gisselbrecht C Mounier N 2004Semin 0ncol2004,31,12:1
17Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front line autotransplantation after complete remission: a cohort study by the Groupe d'Etude des Lymphomes de l'Adulte显示文摘Mounier N Gisselbrecht C Briere J 2004J Clin Oncol2004,22,14:1
18Phase II trial of CHOP plus rituximab in patients with HIV - associated non - Hodgkin's lymphoma显示文摘Bou6 F Gabarre J Gisselbrecht C 2006J Clin Oneol2006,24,25:1
19Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)显示文摘Mounier N Briere J Gisselbrecht C 2003Blood2003,101,11:1
20Rituximab plus CHOP(R-CHOP) overcomes bcl- 2 associated resistance to chemotherapy in elderly patients with diffuse large B- cell lymphoma (DLBCL) 显示文摘Mounier N Briere J Gisselbrecht C 2003Blood2003,101,11:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费